简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-12-13 16:55 MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program
2022-12-13 15:29 Masimo Announces Limited Market Release of Sepsis Index
2022-12-13 14:38 Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union
2022-12-13 09:47 IWBI Launches the WELL Equity Rating to Advance Organizations and Places Where “Everyone Feels Welcome, Seen and Heard”
2022-12-13 09:18 International Conference on Display Technology (ICDT) Awards Universal Display Corporation with Excellent Paper Honor
2022-12-12 09:16 Aptorum Group Announces Offering of $3 Million Convertible Note due 2023
2022-12-09 19:23 Mary Kay Protects Critically Endangered Lemurs and Other Wildlife in Partnership With the Arbor Day Foundation
2022-12-09 09:51 Covetrus Names Ajoy Karna as Chief Financial Officer
2022-12-09 09:40 Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience
2022-12-08 18:42 ESF Seafood Transforms Shrimp Processing With Industry Leading Renewable Energy Conversion
2022-12-08 18:14 Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
2022-12-07 18:29 Affiliates of ZCG Acquire Universal Marine Medical Supply International
2022-12-07 18:25 Phase III trial demonstrated Jardiance is the first SGLT2 inhibitor to show statistically significant reduction in blood sugar levels in children and adolescents with type 2 diabetes
2022-12-07 15:25 Exscientia Presents Novel Immuno-Oncology Biomarker for EXS-21546 at the ESMO I-O Annual Congress
2022-12-05 16:11 Sermo Survey Finds Opportunity to Educate General Care Physicians on PrEP to Increase Patient Adoption
2022-12-05 15:34 New Crown Bioscience Publication Details Application of In Vitro 3D Organoids with Matched PDX for Clinically Relevant Oncology Drug Development
2022-12-02 19:35 The University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health
2022-12-02 19:01 Ferring Receives U.S. FDA Approval for REBYOTA® (fecal microbiota, live-jslm) – A Novel First-in-Class Microbiota-Based Live Biotherapeutic
2022-12-02 13:16 ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)
2022-12-02 10:03 New Prospective Study Finds That Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring Can Help Provide Effective Blood Management in Patients Undergoing Major Surgery

Business Wire Weibo

Press Releases

Latest Releases